Concepedia

Edward F. McKone

EF

Statistics

Publications

34

Citations

6.8K

H-Index

23

Active since

2002

Affiliations

St. Vincent's University Hospital(Current)

University of Washington

University College Dublin

Case Western Reserve University

Vertex Pharmaceuticals (United States)

Edward F. McKone is an author at St. Vincent's University Hospital specializing in cystic fibrosis, cftr gene mutations, and cftr protein function.

Publications per year

2002–2025

34

Publications

34

A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation

Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney et al. · New England Journal of Medicine · 2011 · 2.2K citations · Full text

, , +8

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

, , +15

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

Jennifer L. Taylor‐Cousar, À. Munck, Edward F. McKone et al. · New England Journal of Medicine · 2017 · 778 citations · Full text

, , +10

Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study

Edward F. McKone, Scott S. Emerson, Karen L. Edwards et al. · The Lancet · 2003 · 391 citations

, , +12

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

Michael W. Konstan, Edward F. McKone, Richard B. Moss et al. · The Lancet Respiratory Medicine · 2016 · 286 citations

, , +15

1–5 of 34